The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
Oxford Myeloma Workshop 2025 | Highlights from the Oxford Myeloma Workshop 2025
In this video, Sarah Gooding, MD, PhD, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK, shares some of her highlights from the 5th Oxford Myeloma Workshop, stating that the combination of talks from all areas of multiple myeloma (MM) research created an exciting and comprehensive experience. The integration of patient viewpoints through the “Grill an Expert” sessions also added a valuable layer to the event. This interview took place at the 5th Oxford Myeloma Workshop in Oxford, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Transcript (AI-generated)
For me personally, there was an awful lot that was very exciting in the Oxford Myeloma Workshop and I think that stemmed from the fact that we had a mixture of talks from different parts of myeloma research. So we had some talks about clinical trials, summarising the clinical trial landscape at the moment, new therapies, new drug approvals that are coming through. But then we also had a really sizable number of talks that were about more translational or basic scientific research, and I think the fact that we mixed all of those up together was one of the real highlights of the meeting...
For me personally, there was an awful lot that was very exciting in the Oxford Myeloma Workshop and I think that stemmed from the fact that we had a mixture of talks from different parts of myeloma research. So we had some talks about clinical trials, summarising the clinical trial landscape at the moment, new therapies, new drug approvals that are coming through. But then we also had a really sizable number of talks that were about more translational or basic scientific research, and I think the fact that we mixed all of those up together was one of the real highlights of the meeting. And in amongst all of that we also had some patient viewpoints expressed as part of our grill an expert session. So the fact that we interwove all of those things together meant that we moved from discussions about clinical practice right through to novel techniques in myeloma research. And we kind of put those together and contextualized them together. And I think that was not something that’s normally done, but the overwhelming feedback we’ve had is that the audience really appreciated that, whether they were a clinician, a scientist, or whatever their background.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.
Read more...
